Current pain management strategies for patients with erythromelalgia: a critical review

Abstract

See Wan Tham,1,2 Marian Giles1,2 1Seattle Children’s Research Institute, Seattle, WA, USA; 2Department of Anesthesiology and Pain Medicine, University of Washington School of Medicine, Seattle, WA, USA Abstract: Erythromelalgia (EM) is a rare disorder characterized by erythematous, warm, painful extremities, which is often precipitated by cold conditions. The pathophysiology of EM is incompletely understood. Recent investigations have identified sodium channelopathy as a genetic cause for this pain condition, classified as primary inherited EM. Other subtypes are idiopathic EM and secondary EM. The management of pain in EM is challenging as no single therapy has been found to be effective. There is varying response to pharmacotherapy and significant variability within this clinical population, resulting in a stepwise trial and error approach. Consequently, EM is often associated with poorer health-related quality of life with higher morbidity. There is currently no consensus or guidelines on management of pain in EM. This is a review of the literature on management of pain using pharmacologic, procedural intervention and nonpharmacologic treatment in children and adults with EM. Keywords: erythromelalgia, pain, voltage gated sodium channel, therapy

Keywords

• Erythromelalgia Pain Pharmacotherapy